Auxo Firm Directory · Independent Research Profile

Physician Growth Partners

Physician Growth Partners describes itself as a healthcare-focused investment bank and transaction advisory firm. Its stated work includes recapitalizations, mergers and acquisitions, and sales to private equity and strategic acquirers across physician, dental, outpatient, behavioral, ancillary, and related healthcare services.

Key takeaway

PGP is a sell-side-focused healthcare investment banking and M&A advisory firm.

It states that it serves healthcare groups pursuing mergers, acquisitions, recapitalizations, or full transaction sales, with represented groups ranging from $10 million to over $150 million in revenue.[1][2][3]

What does Physician Growth Partners do?

Physician Growth Partners (PGP) is a healthcare investment banking and transaction advisory firm focused on representing healthcare organizations. It states that it advises on recapitalizations, mergers and acquisitions, and sales to private equity and strategic acquirers.

PGP’s FAQ states that it has represented healthcare groups ranging from $10 million to over $150 million in revenue. The firm also states that it advises healthcare services organizations nationwide and that completed transactions span nearly every state in the country.[1][2]

PGP publicly describes its services as sell-side healthcare investment banking and transaction advisory work. Its stated focus includes recapitalizations, mergers and acquisitions, and sales to private equity and strategic acquirers.

PGP’s FAQ identifies healthcare groups pursuing a merger, acquisition, recapitalization, or full transaction sale as its core client focus.[1][2]

Owners comparing advisory firms can also review Auxo’s M&A advisor vs. business broker vs. investment bank comparison, advisor-selection guide, and sell-side advisor evaluation framework.

RevenuePublicly stated range
Lower published point$10MILLION
Upper published point$150MILLION

Published criteria: PGP's FAQ states that it has represented healthcare groups ranging from $10 million to over $150 million in revenue.[2]

What should a business owner evaluate before hiring Physician Growth Partners?

Owners of physician, dental, behavioral-health, outpatient, ancillary, or related healthcare-services businesses can evaluate PGP against its stated healthcare specialization, transaction mandate, and client revenue range of $10 million to over $150 million. The firm’s stated nationwide coverage and specialty experience provide areas to discuss in relation to a particular business.

Owners should clarify the proposed buyer universe, transaction structure, valuation expectations, senior banker participation, and treatment of physician ownership, governance, employment, and clinical autonomy. PGP’s FAQ does not state standard engagement economics, so fee, expense, tail, exclusivity, and termination provisions should be addressed directly.[1][2][3]

01

What buyer universe and process design would PGP recommend for the owner's specialty and geography

PGP states that it advises healthcare organizations nationwide and has experience across multiple healthcare sectors and specialties.[1][2][3]
02

What valuation range and transaction structures are realistic, including cash at close, rollover equity, earnouts, and contingent consideration

PGP’s 2025 year-in-review reports aggregate transaction statistics but does not disclose individual transaction consideration, valuation, financing terms, or fee arrangements for the listed transactions.[3]
03

Which senior bankers would lead the engagement and how frequently would they participate

PGP states that senior healthcare investment banking professionals are involved at every stage of the transaction process.[1]

What size transactions and clients does Physician Growth Partners focus on?

PGP states that it has expertise across physician and dental services; outpatient and ambulatory care; ancillary and diagnostic services; post-acute and behavioral care; and healthcare support and administrative services.

Specialties identified in the firm’s 2025 year-in-review include behavioral health, ENT/allergy/asthma, pediatrics, oral surgery, women’s health, dermatology, ophthalmology, orthopedics, pain management, ambulatory surgery centers, dental, urology, gastroenterology, plastic surgery, and cardiology.[1][3]

The official press-release archive lists PGP’s July 29, 2026 advisory assignment for Golden Gate Urology in its transaction with Unio Specialty Care. It also lists the firm’s June 23, 2026 advisory assignment for Lakeshore ENT in its strategic partnership with Align ENT + Allergy and its June 17, 2026 advisory assignment for Michigan Ear Institute in its strategic partnership with Align ENT & Allergy.

PGP’s 2025 year-in-review states that the firm completed 12 transactions across 9 healthcare sectors, worked with groups across 15 states, and generated $400MM+ in total transaction value during 2025.[3][7]

PGP states that it represents healthcare organizations in recapitalizations, mergers and acquisitions, and sales to private equity and strategic acquirers. Its FAQ also identifies full transaction sales and mergers as part of its client focus.

Publicly listed assignments include transactions involving private equity-backed platforms, strategic partnerships, and healthcare organizations.[1][2][7]

What does Physician Growth Partners publicly disclose about fees, process and engagement terms?

PGP’s FAQ does not state a universal advisory-fee percentage, minimum fee, tail period, termination schedule, or other standard engagement economics.

PGP’s 2025 year-in-review reports aggregate transaction statistics but does not disclose individual transaction consideration, valuation, financing terms, or fee arrangements for the listed transactions.

PGP’s FAQ does not establish whether Physician Growth Partners or a named affiliated legal entity is registered as a broker-dealer, investment adviser, or other regulated financial-services firm.[2][3]

PGP’s official FAQ identifies the firm as a nationally recognized investment bank exclusively focused on healthcare. Its official materials also characterize the firm as a healthcare investment banking and M&A advisory firm.

PGP’s FAQ does not establish whether Physician Growth Partners or a named affiliated legal entity is registered as a broker-dealer, investment adviser, or other regulated financial-services firm.[1][2]

PGP states that senior healthcare investment banking professionals are involved at every stage of the transaction process and bring healthcare-sector expertise, execution capabilities, and long-standing relationships.[1]

Questions to ask before hiring Physician Growth Partners

What buyer universe and process design would PGP recommend for the owner's specialty and geography?
PGP states that it advises healthcare organizations nationwide and has experience across multiple healthcare sectors and specialties.[1][2][3]
What valuation range and transaction structures are realistic, including cash at close, rollover equity, earnouts, and contingent consideration?
PGP’s 2025 year-in-review reports aggregate transaction statistics but does not disclose individual transaction consideration, valuation, financing terms, or fee arrangements for the listed transactions.[3]
Which senior bankers would lead the engagement and how frequently would they participate?
PGP states that senior healthcare investment banking professionals are involved at every stage of the transaction process.[1]
What are the proposed advisory fee, expense, tail, exclusivity, and termination provisions?
PGP’s FAQ does not state a universal advisory-fee percentage, minimum fee, tail period, termination schedule, or other standard engagement economics.[2]
How does PGP manage conflicts when a buyer or platform has appeared in prior transactions?
PGP publicly lists advisory assignments involving strategic partnerships, private equity-backed platforms, and strategic acquirers, making conflict-management practices a matter to clarify for a proposed engagement.[1][7]
What physician ownership, governance, employment, and clinical-autonomy terms should the owner expect in a proposed transaction?
PGP states that it represents healthcare organizations in sales, recapitalizations, mergers and acquisitions, and strategic partnerships. The cited claims do not specify standard physician ownership, governance, employment, or clinical-autonomy terms.[1][2]

Sources & research notes

Public-source research
  1. Official website / firm overview
  2. Services / capabilities
  3. Industry focus
  4. Geography / market coverage
  5. Transaction / portfolio evidence
  6. Transaction / portfolio evidence
  7. Transaction / portfolio evidence
Prepared and reviewed by: Auxo Capital AdvisorsEvidence standard: Public-source verification

How this profile was researched

Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.

Independent profile & regulatory context

Independent research profile

This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.

Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.

Broker-dealer and securities disclosure

Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.

Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.

Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.

Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.